By Peter A. McCullough, MD, MPH, Baylor University Medical Center, Dallas TX
There is considerable attention on the potential to be infected a second or third or fourth time with SARS-CoV-2 and be hospitalized over and over again with COVID-19. Thankfully, at over 110 million cases worldwide, we have not seen thousands of rehospitalizations. In fact, reports of possible recurrence are very rare, yet are used as public health rationale for COVID-19 recovered patients to undergo vaccination with its intendant risks including death.
A recent case from France reported that a 58-year-old man had a brief illness with a positive SARS-CoV-2 nasal PCR test in September 2020 and then was infected with the South African variant 501Y.V2 strain in January 2021 and was hospitalized and required mechanical ventilation. Although details are not given, when the nasal PCR test is run at cycle thresholds >35 ct, the test picks up pieces of RNA in the nasal secretions from influenza and other viral fragments. Since the patient is 58 and has asthma, the September illness was almost certainly not COVID-19, since in a man his age and with asthma COVID-19 will last for 14 to 30 days or more. His first and real COVID-19 illness occurred in January 2021.
The rumor that the AMA rescinded its March statement discouraging the use of Hydroxychloroquine for COVID-19 had gone viral. But the sad truth of the matter is that the rumor isn’t true. The AMA refuses to stand for patients and agree to let doctors be doctors.
So what happened?
A brave group of physicians led by Atlanta rheumatologist John Goldman, MD were compelled to try to reverse the AMA’s dangerous position against early treatment. So they drafted a resolution and took it to the AMA House of Delegates for consideration.
Unfortunately AMA Leadership decided to make sure the resolution failed. In the committee hearings at the meeting the “AMA Board of Trustees (BOT) provided testimony in opposition of this Resolution and supportive of the AMA statement.”
The result? The resolution brought by Dr. Goldman and his colleagues was defeated.
It is clear more than ever that AMA decisions are based on a political agenda. It the organization’s decisions were evidence based then the bad policy would never have been put in place to begin with. Because the evidence is clear, HCQ and other common inexpensive medications are saving lives (https://c19study.com/.)
PBM stands for Pharmacy Benefit Manager. Examples are Caremark (CVS Health); Express Scripts; OptumRx; Humana Pharmacy Solutions.
GPO stands for Group Purchasing Organization. Examples are Premier; Vizient; Intalere; Cardinal Health.
These corporate giants are wealthymiddlemen that control the pharmaceutical and medical device markets in the United States.
Much of their power and wealth derive from “acts of Congress,” which established a “safe harbor” (42 U.S.C. 1320a-7b(b)(3)(C)) for GPOs and PBMs to receive kickbacks from manufacturers of drugs, medical solutions, and medical devices. Unlike nearly all companies operating in other sectors of the economy, the middlemen in the American healthcare system can collect kickbacks without fear of prosecution.